Literature DB >> 22436845

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22436845     DOI： 10.1016/j.jhep.2012.02.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  995 in total

1.  Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors:  Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.

Authors:  Jie Zeng; Jian Zheng; Jie-Yang Jin; Yong-Jiang Mao; Huan-Yi Guo; Ming-De Lu; Hai-Rong Zheng; Rong-Qin Zheng
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

3.  Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Authors:  Bulent Baran; Ozlem Mutluay Soyer; Asli Cifcibasi Ormeci; Suut Gokturk; Sami Evirgen; Hamza Ugur Bozbey; Filiz Akyuz; Cetin Karaca; Kadir Demir; Fatih Besisik; Derya Onel; Mine Gulluoglu; Selim Badur; Sabahattin Kaymakoglu
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 4.  Liver diseases in pregnancy: diseases not unique to pregnancy.

Authors:  Ashraf A Almashhrawi; Khulood T Ahmed; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 5.  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 6.  Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.

Authors:  Rui Yu; Rong Fan; Jinlin Hou
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

7.  Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.

Authors:  Cuiling Yang; Na Li; Yawen Wang; Pingping Zhang; Qianqian Zhu; Fang Li; Qunying Han; Yi Lv; Ling Yu; Ping Wei; Zhengwen Liu
Journal:  J Interferon Cytokine Res       Date:  2014-05-08       Impact factor: 2.607

8.  Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.

Authors:  Su-Wen Jiang; Li-Peng Yao; Ai-Rong Hu; Yao-Ren Hu; Shi-Xiang Chen; Tao Xiong; Guo-Sheng Gao; Xiao-Yue Liang; Shi-Xiong Ding; Peng-Jian Weng
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 9.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

10.  Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.

Authors:  Scott Bowden; Stephen Locarnini; Ting-Tsung Chang; You-Chen Chao; Kwang-Hyub Han; Robert G Gish; Robert A de Man; Miao Yu; Cyril Llamoso; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.